Childress Capital Advisors’s Anterix ATEX Stock Holding History

Childress Capital Advisors’s Portfolio ATEX Stock Details ATEX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-143	Closed	-$5K	–	223
2020 Q4	$5K	Buy	+143	New	+$4.71K	﹤0.01%	732

Other funds holding ATEX

OCAM

Owl Creek Asset Management New York $1.21B AUM 169.99% 1-Year Est. Return

Allianz Asset Management Munich, Germany $123B AUM 45.23% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BCC

Bain Capital Credit Boston, Massachusetts $368M AUM 9.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

MFP

Michael F. Price $846M AUM 0.07% 1-Year Est. Return

SSP

Sixth Street Partners Dallas, Texas $579M AUM 2.46% 1-Year Est. Return

QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Childress Capital Advisors's ATEX Position: Q1 2021 in Review

Childress Capital Advisors sold out of Anterix (ATEX) in Q1 2021, closing a stake of 143 shares — an estimated $5K sold.

Childress Capital Advisors first reported a position in ATEX in Q4 2020 and held it in 1 quarter. The position peaked at $5K in Q4 2020. 97 funds tracked by Wall St. Rank hold ATEX as of Q1 2021.

Childress Capital Advisors reported no remaining Anterix position as of Q1 2021 after selling out during the quarter.
Childress Capital Advisors sold 143 Anterix shares in Q1 2021, an estimated $5K.
Childress Capital Advisors first reported a position in Anterix in Q4 2020 and held it in 1 quarter.
Childress Capital Advisors's Anterix position peaked at $5K in Q4 2020.
97 funds tracked by Wall St. Rank held Anterix as of Q1 2021.

Based on Childress Capital Advisors's 13F filing for Q1 2021, filed 21 May 2021.